Drug Shortage Report for FOQUEST
Report ID | 152470 |
Drug Identification Number | 02470322 |
Brand name | FOQUEST |
Common or Proper name | methylphenidate hydrochloride Controlled Release Capsules |
Company Name | ELVIUM LIFE SCIENCES |
Market Status | MARKETED |
Active Ingredient(s) | METHYLPHENIDATE HYDROCHLORIDE |
Strength(s) | 55MG |
Dosage form(s) | CAPSULE (CONTROLLED RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 60 |
ATC code | N06BA |
ATC description | PSYCHOSTIMULANTS AND NOOTROPICS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2022-01-11 |
Actual start date | 2022-01-11 |
Estimated end date | 2022-02-18 |
Actual end date | 2022-02-16 |
Shortage status | Resolved |
Updated date | 2022-02-17 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3381 STEELES AVENUE EAST TORONTO, ONTARIO CANADA M2H 3S7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v13 | 2022-02-17 | French | Compare |
v12 | 2022-02-17 | English | Compare |
v11 | 2022-02-11 | French | Compare |
v10 | 2022-02-11 | English | Compare |
v9 | 2022-02-04 | French | Compare |
v8 | 2022-02-04 | English | Compare |
v7 | 2022-02-03 | French | Compare |
v6 | 2022-02-03 | English | Compare |
v5 | 2022-01-20 | French | Compare |
v4 | 2022-01-20 | English | Compare |
v3 | 2022-01-12 | English | Compare |
v2 | 2022-01-11 | French | Compare |
v1 | 2022-01-11 | English | Compare |
Showing 1 to 13 of 13